One of the important goals of Biomedicum Helsinki - the medical research and training center on the Meilahti campus - is to provide an optimal environment for active and productive collaboration between basic scientists and clinical investigators (physician scientists).
The building houses several basic science departments of the University of Helsinki (Institute of Biomedicine, and Institute of Dentistry together with Departments of Clinical Pharmacology and Medical Genetics) along with laboratory research units of the Helsinki University Central Hospital for physician scientists whose primary appointment is within the Helsinki University Central Hospital. The mere presence of basic scientists and clinical investigators in the same building promotes the establishment of joint research projects for the benefit of both parties.
An important special means to foster and facilitate collaboration between basic scientists and physician scientists will be achieved through the six Research Programs established at the Biomedicum Helsinki building. The current six programs were selected on the basis of the evaluation by the Scientific Advisory Board of Biomedicum Helsinki. The space has been allocated to the programs for five years.
The programs report to the Director of Biomedicum Helsinki, and an international Scientific Advisory Board will review the programs towards the end of their five-year term.
The research programs for the years 2013 - 2017 are as follows:
Director: Mikael Knip, Professor, mikael.knip (at) hus.fi
Work on normal and disturbed cell function via genome-wide approaches, with the objective of applying the research results in diagnostic and/or therapeutic purposes.
Director: Lauri Aaltonen, Research Professor, lauri.aaltonen (at) helsinki.fi
Study of molecular and cell-level phenomena in microbes and the host during invasion and infection by pathogens. The objective is to find new pathogens, diagnostic tests, and forms of treatment.
Director: Mikael Skurnik, Professor, mikael.skurnik (at) helsinki.fi
Production of new knowledge about the pathogenetic mechanisms of cancer and identification of new genes and their modifying factors. In particular, DNA damage response, stem cells of cancer, and lymphangiogenesis/angiogenesis are being studied.
Director: Kari Alitalo, Academy Professor, kari.alitalo (at) helsinki.fi
Clarification of molecular-level events in neurological and neuropsychiatric diseases by searching for disease and susceptibility genes and studying disease mechanisms. The research knowledge is utilized in the diagnosis and treatment of diseases.
Director: Anu Wartiovaara, Professor, anu.wartiovaara (at) helsinki.fi